IP Portfolio Summary
Sangui Bio has a strong and broad patent portfolio, that is managed by the leading US legal and patent firm – Jones Day. The portfolio comprises three patent applications currently undergoing national phase examination based on recent discoveries in red blood cell biology. The first PCT application published in April 2017.
Blood preparation and profiling (WO2017059477A1)
Therapeutic methods using erythrocytes (WO2017106899A2)
Karsten E, Herbert B, Liddle A, Hill C. Therapeutic methods using erythrocytes. Priority date: 2015-12-22. Stage: National phase examination.
Blood profiling with protease inhibitors (WO2018112500A1)
Karsten E, Herbert B, Liddle A, Hill C. Blood preparation and profiling. Priority date: 2015-10-07. Stage: National phase examination.